Although these GLP-1 receptor agonists have different active ingredients (Wegovy and Ozempic use semaglutide, a once-weekly injection, whereas Saxenda uses liraglutide, which is a daily injection), many options have demonstrated weight loss of 5-21%
This fusion may enable the release of growth hormone outside the pituitary cells, possibly allowing it to exert biological action
Stimulates Collagen and Elastin Synthesis: GHK-Cu upregulates genes associated with collagen, elastin, and glycosaminoglycan production, improving skin firmness and extracellular matrix integrity 3
A large study published in The BMJ on July 22 reported that adults with type 2 diabetes taking GLP-1 medicines such as semaglutide were more likely to be diagnosed with hair loss than those on other diabetes drugs
The GHS R1a receptor also exhibits constitutive activity, meaning it maintains a tonic signal that supports normal growth hormone output even without a ligand present
AK: Conceptualization, Writing review & editing, Supervision, Writing original draft, Methodology
